ProMap® T cell Proliferation Assay Publications

Mande P., et al. (2025). “Discovery and characterization of a novel engineered Fc-fused IgE cleaving enzyme for treatment of IgE mediated diseases.” Journal of Allergy and Clinical Immunology, 155AB172. https://doi.org/10.1016/j.jaci.2024.12.544

Trimpont MV., et al. (2025). “A human-like glutaminase-free asparaginase is highly efficacious in ASNSlow leukemia and solid cancer mouse xenograft models.” Cancer Letters, Volume 611, 2025, 217404, ISSN 0304-3835. https://doi.org/10.1016/j.canlet.2024.217404.

Wilkinson I, et al. (2021). “Fc-engineered antibodies with immune effector functions completely abolished.” PLOS ONE 16(12): e0260954. https://doi.org/10.1371/journal.pone.0260954

Grant E. Blouse., et al. (2019). “Title of Poster: A Comprehensive In Silico And In Vitro Immunogenicity Risk Assessment of Dalcinonacog Alfa Shows No Increased Risk Compared With Wild-type FIX.“.

Lyn M. O’Brien, et al. (2012). “A humanised murine monoclonal antibody protects mice from Venezuelan equine encephalitis virus, Everglades virus and Mucambo virus when administered up to 48h after airborne challenge.“
Virology, Volume 426, Issue 2, 2012, Pages 100-105, ISSN 0042-6822. https://doi.org/10.1016/j.virol.2012.01.038.